Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SNSE Sensei Biotherapeutics Inc

0.019 (2.29%)
After Hours
Last Updated: 16:02:00
Delayed by 15 minutes


Draw Mode:

Volume 118,615
Bid Price 0.8251
Ask Price 0.90
News -
Day High 0.8696


52 Week Range


Day Low 0.7874
Company Name Stock Ticker Symbol Market Type
Sensei Biotherapeutics Inc SNSE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.019 2.29% 0.849 16:02:00
Open Price Low Price High Price Close Price Prev Close
0.8085 0.7874 0.8696 0.849 0.83
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
394 118,615 $ 0.8043759 $ 95,411 - 0.51 - 1.94
Last Trade Time Type Quantity Stock Price Currency
16:00:02 229 $ 0.849 USD

Sensei Biotherapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
21.31M 25.07M - 0 -34.1M -1.36 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sensei Biotherapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No SNSE Message Board. Create One! See More Posts on SNSE Message Board See More Message Board Posts

Historical SNSE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.451.540.68761.00776,455-0.601-41.45%
1 Month1.001.940.68761.46595,324-0.151-15.10%
3 Months0.9451.940.68761.36248,728-0.096-10.16%
6 Months0.651.940.597751.24146,4280.19930.62%
1 Year1.451.940.511.1790,529-0.601-41.45%
3 Years12.4713.000.513.4685,290-11.62-93.19%
5 Years24.7026.380.516.1897,775-23.85-96.56%

Sensei Biotherapeutics Description

Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused, and coordinated innate and adaptive immune response.

Your Recent History

Delayed Upgrade Clock